{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T11:41:27Z","timestamp":1790509287034,"version":"4.1.0"},"reference-count":52,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2017,7,12]],"date-time":"2017-07-12T00:00:00Z","timestamp":1499817600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutrients"],"abstract":"<jats:p>Upregulated arginase activity, which competes with nitric oxide synthase (NOS), impairs nitric oxide production and has been implicated in various metabolic disorders. This study examined whether circulating amino acid metabolite ratios are associated with arginase and NOS activities and whether arginine bioavailability is associated with metabolic syndrome (MetS). Data related to arginase and NOS activities were collected from non-diabetic Koreans without cardiovascular disease (n = 1998) in the Ansan\u2013Ansung cohorts (2005\u20132006). Subsequently, correlation and multivariate logistic regression analyses were performed. With the increase in the number of MetS risk factors, ratios of circulating amino acid metabolites, such as those of ornithine\/citrulline, proline\/citrulline, and ornithine\/arginine, also significantly increased, whereas arginine bioavailability significantly decreased. These metabolite ratios and arginase bioavailability were also significantly correlated with MetS risk-related parameters, which remained significant after adjusting for covariates. In addition, logistic regression analysis revealed that high ratios of circulating metabolites and low arginine bioavailability, which indicated increased arginase activity, were significantly associated with a high MetS risk. This study demonstrated that altered ratios of circulating amino acid metabolites indicates increased arginase activity and decreased arginine bioavailability, both of which can be potential markers for MetS risk.<\/jats:p>","DOI":"10.3390\/nu9070740","type":"journal-article","created":{"date-parts":[[2017,7,12]],"date-time":"2017-07-12T10:36:12Z","timestamp":1499855772000},"page":"740","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Alterations in Circulating Amino Acid Metabolite Ratio Associated with Arginase Activity Are Potential Indicators of Metabolic Syndrome: The Korean Genome and Epidemiology Study"],"prefix":"10.3390","volume":"9","author":[{"given":"Jiyoung","family":"Moon","sequence":"first","affiliation":[{"name":"Department of Public Health Sciences, BK21PLUS Program in Embodiment: Health-Society Interaction, Graduate School, Korea University, Seoul 02841, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9262-3309","authenticated-orcid":false,"given":"Oh","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Food Science and Nutrition, Dong-A University, Busan 49315, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garam","family":"Jo","sequence":"additional","affiliation":[{"name":"Department of Public Health Sciences, BK21PLUS Program in Embodiment: Health-Society Interaction, Graduate School, Korea University, Seoul 02841, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-Jeong","family":"Shin","sequence":"additional","affiliation":[{"name":"Department of Public Health Sciences, BK21PLUS Program in Embodiment: Health-Society Interaction, Graduate School, Korea University, Seoul 02841, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2017,7,12]]},"reference":[{"key":"ref_1","unstructured":"International Diabetes Federation (IDF) (2006). IDF Consensus Worldwide Definition of the Metabolic Syndrome, International Diabetes Federation (IDF)."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1056\/NEJMp068177","article-title":"Obesity and diabetes in the developing world\u2014A growing challenge","volume":"2007","author":"Hossain","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1056\/NEJMhpr060227","article-title":"Obesity\u2014The new frontier of public health law","volume":"354","author":"Mello","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Kaur, J. (2014). A comprehensive review on metabolic syndrome. Cardiol. Res. Pract., 2014.","DOI":"10.1155\/2014\/943162"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1001\/jama.288.21.2709","article-title":"The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men","volume":"288","author":"Lakka","year":"2006","journal-title":"JAMA"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","article-title":"Harmonizing the metabolic syndrome. A joint interim statement of the international diabetes federation task force on epidemiology and prevention; national heart, lung and blood institute; american heart association; world heart federation; international atherosclerosis society; and international atherosclerosis for the study of obesity","volume":"120","author":"Alberti","year":"2009","journal-title":"Circulation"},{"key":"ref_7","first-page":"24","article-title":"Metabolic syndrome: Nonalcoholic fatty liver disease","volume":"435","author":"Williams","year":"2015","journal-title":"FP Essent."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/S0002-9343(99)00271-5","article-title":"Association of nonalcoholic fatty liver disease with insulin resistance","volume":"107","author":"Marchesini","year":"1999","journal-title":"Am. J. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.2337\/diabetes.50.8.1844","article-title":"Nonalcoholic fatty liver disease","volume":"50","author":"Marchesini","year":"2001","journal-title":"Diabetes"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1161\/CIRCULATIONAHA.112.140335","article-title":"Arginase inhibition improves endothelial function in patients with coronary artery disease and type 2 diabetes mellitusclinical perspective","volume":"126","author":"Shemyakin","year":"2012","journal-title":"Circulation"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Moon, J., Do, H.J., Cho, Y., and Shin, M.-J. (2014). Arginase inhibition ameliorates hepatic metabolic abnormalities in obese mice. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0103048"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.bbrc.2014.07.083","article-title":"Arginase inhibition restores endothelial function in diet-induced obesity","volume":"451","author":"Chung","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s00726-010-0598-z","article-title":"Beneficial effects of l-arginine on reducing obesity: Potential mechanisms and important implications for human health","volume":"39","author":"McKnight","year":"2010","journal-title":"Amino Acids"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s00726-009-0246-7","article-title":"High fat feeding and dietary l-arginine supplementation differentially regulate gene expression in rat white adipose tissue","volume":"37","author":"Jobgen","year":"2009","journal-title":"Amino Acids"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1007\/s00726-011-1199-1","article-title":"l-Arginine improves multiple physiological parameters in mice exposed to diet-induced metabolic disturbances","volume":"43","author":"Clemmensen","year":"2012","journal-title":"Amino Acids"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"230","DOI":"10.3945\/jn.108.096362","article-title":"Dietary l-arginine supplementation reduces white fat gain and enhances skeletal muscle and brown fat masses in diet-induced obese rats","volume":"139","author":"Jobgen","year":"2008","journal-title":"J. Nutr."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1093\/jn\/135.4.714","article-title":"Dietary l-arginine supplementation reduces fat mass in zucker diabetic fatty rats","volume":"135","author":"Fu","year":"2005","journal-title":"J. Nutr."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.tips.2015.03.006","article-title":"Arginase: An old enzyme with new tricks","volume":"36","author":"Caldwell","year":"2015","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1161\/CIRCRESAHA.108.175570","article-title":"Arginine and arginase","volume":"102","author":"Vanhoutte","year":"2008","journal-title":"Circ. Res."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1093\/cvr\/cvt036","article-title":"Arginase as a potential target in the treatment of cardiovascular disease: Reversal of arginine steal?","volume":"98","author":"Pernow","year":"2013","journal-title":"Cardiovasc. Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/ng.357","article-title":"A large-scale genome-wide association study of asian populations uncovers genetic factors influencing eight quantitative traits","volume":"41","author":"Cho","year":"2009","journal-title":"Nat. Genet."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"S498","DOI":"10.1097\/00005768-200009001-00009","article-title":"Compendium of physical activities: An update of activity codes and met intensities","volume":"32","author":"Ainsworth","year":"2000","journal-title":"Med. Sci. Sports Exerc."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge","volume":"18","author":"Friedewald","year":"1972","journal-title":"Clin. Chem."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (2001). Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel iii). JAMA, 285, 2486\u20132497.","DOI":"10.1001\/jama.285.19.2486"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.3346\/jkms.2006.21.6.1048","article-title":"Cut-off values of visceral fat area and waist circumference: Diagnostic criteria for abdominal obesity in a korean population","volume":"21","author":"Kim","year":"2006","journal-title":"J. Korean Med. Sci."},{"key":"ref_26","first-page":"612","article-title":"Obesity: A review of currently used antiobesity drugs and new compounds in clinical development","volume":"61","author":"Zieba","year":"2006","journal-title":"Postep. Hig. Med. Doswiadczalnej"},{"key":"ref_27","first-page":"312","article-title":"Obesity drugs in clinical development","volume":"7","author":"Halford","year":"2006","journal-title":"Curr. Opin. Investig. Drugs"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.nut.2011.09.012","article-title":"Arginase I and the very low-density lipoprotein receptor are associated with phenotypic biomarkers for obesity","volume":"28","author":"Kim","year":"2012","journal-title":"Nutrition"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1161\/CIRCRESAHA.107.162701","article-title":"Mechanisms of endothelial dysfunction induced by aging","volume":"101","author":"Katusic","year":"2007","journal-title":"Circ. Res."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s11906-006-0041-8","article-title":"Endothelial arginase: A new target in atherosclerosis","volume":"8","author":"Yang","year":"2006","journal-title":"Curr. Hypertens. Rep."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1093\/cvr\/cvq081","article-title":"Cardiovascular effects of arginase inhibition in spontaneously hypertensive rats with fully developed hypertension","volume":"87","author":"Bagnost","year":"2010","journal-title":"Cardiovasc. Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1097\/HJH.0b013e3282fcc357","article-title":"Treatment with the arginase inhibitor N\u03c9-hydroxy-nor-l-arginine improves vascular function and lowers blood pressure in adult spontaneously hypertensive rat","volume":"26","author":"Bagnost","year":"2008","journal-title":"J. Hypertens."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1002\/art.30391","article-title":"Endothelial dysfunction in rat adjuvant-induced arthritis: Up-regulation of the vascular arginase pathway","volume":"63","author":"Prati","year":"2011","journal-title":"Arthritis Rheum."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"R130","DOI":"10.1186\/ar3860","article-title":"Treatment with the arginase inhibitor Nw-hydroxy-nor-l-arginine restores endothelial function in rat adjuvant-induced arthritis","volume":"14","author":"Prati","year":"2012","journal-title":"Arthritis Res. Ther."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"e12130","DOI":"10.14814\/phy2.12130","article-title":"Arginase inhibition augments nitric oxide production and facilitates left ventricular systolic function in doxorubicin-induced cardiomyopathy in mice","volume":"2","author":"Toya","year":"2014","journal-title":"Physiol. Rep."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/joim.12461","article-title":"Arginase inhibition improves endothelial function in patients with familial hypercholesterolaemia irrespective of their cholesterol levels","volume":"279","author":"Kovamees","year":"2016","journal-title":"J. Intern. Med."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"H1174","DOI":"10.1152\/ajpheart.00560.2010","article-title":"Arginase inhibition restores in vivo coronary microvascular function in type 2 diabetic rats","volume":"300","author":"Jung","year":"2011","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1164\/rccm.200309-1304OC","article-title":"Decreased arginine bioavailability and increased serum arginase activity in asthma","volume":"170","author":"Morris","year":"2004","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/bph.12144","article-title":"Arginase inhibition alleviates hypertension in the metabolic syndrome","volume":"169","author":"Fahmy","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"H1988","DOI":"10.1152\/ajpheart.1996.271.5.H1988","article-title":"Arginase activity in endothelial cells: Inhibition by NG-hydroxy-l-arginine during high-output NO production","volume":"271","author":"Buga","year":"1996","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1161\/01.RES.0000247034.24662.b4","article-title":"Oxidized low-density lipoprotein\u2013dependent endothelial arginase II activation contributes to impaired nitric oxide signaling","volume":"99","author":"Ryoo","year":"2006","journal-title":"Circ. Res."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"C952","DOI":"10.1152\/ajpcell.00466.2009","article-title":"Thrombin induces endothelial arginase through AP-1 activation","volume":"298","author":"Zhu","year":"2010","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.bbrc.2015.07.048","article-title":"Arginase inhibition ameliorates adipose tissue inflammation in mice with diet-induced obesity","volume":"464","author":"Hu","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1006\/bbrc.2001.4874","article-title":"Increased expression of arginase II in human diabetic corpus cavernosum: In diabetic-associated erectile dysfunction","volume":"283","author":"Bivalacqua","year":"2001","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1161\/CIRCRESAHA.107.155028","article-title":"Diabetes-induced coronary vascular dysfunction involves increased arginase activity","volume":"102","author":"Romero","year":"2008","journal-title":"Circ. Res."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.atherosclerosis.2012.12.014","article-title":"Arginase inhibition prevents the low shear stress-induced development of vulnerable atherosclerotic plaques in ApoE\u2212\/\u2212 mice","volume":"227","author":"Olivon","year":"2013","journal-title":"Atherosclerosis"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.freeradbiomed.2014.05.016","article-title":"Regulation of obesity and insulin resistance by nitric oxide","volume":"73","author":"Sansbury","year":"2014","journal-title":"Free Radic. Biol. Med."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1161\/ATVBAHA.108.169722","article-title":"Vascular inflammation, insulin resistance, and reduced nitric oxide production precede the onset of peripheral insulin resistance","volume":"28","author":"Kim","year":"2008","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1111\/j.1463-1326.2006.00650.x","article-title":"Diet-induced obesity and diabetes reduce coronary responses to nitric oxide due to reduced bioavailability in isolated mouse hearts","volume":"9","author":"Bender","year":"2007","journal-title":"Diabetes Obes. Metab."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1038\/sj.ijo.0803795","article-title":"Obesity reduces the bioavailability of nitric oxide in juveniles","volume":"32","author":"Gruber","year":"2008","journal-title":"Int. J. Obes."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1161\/CIRCRESAHA.112.266395","article-title":"Overexpression of endothelial nitric oxide synthase prevents diet-induced obesity and regulates adipocyte phenotypenovelty and significance","volume":"111","author":"Sansbury","year":"2012","journal-title":"Circ. Res."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.jnutbio.2005.12.001","article-title":"Regulatory role for the arginine-nitric oxide pathway in metabolism of energy substrates","volume":"17","author":"Jobgen","year":"2006","journal-title":"J. Nutr. Biochem."}],"container-title":["Nutrients"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6643\/9\/7\/740\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T18:42:21Z","timestamp":1760208141000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6643\/9\/7\/740"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,12]]},"references-count":52,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2017,7]]}},"alternative-id":["nu9070740"],"URL":"https:\/\/doi.org\/10.3390\/nu9070740","relation":{},"ISSN":["2072-6643"],"issn-type":[{"value":"2072-6643","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,12]]}}}